Tsuchiya Taketsugu, Iida Osamu, Shiraki Tatsuya, Soga Yoshimitsu, Hirano Keisuke, Suzuki Kenji, Yamaoka Terutoshi, Miyashita Yusuke, Kitayama Michihiko, Kajinami Koji
Division of Trans-catheter Cardiovascular Therapeutics, Kanazawa Medical University Hospital, Kahoku, Japan.
Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan.
SAGE Open Med. 2015 Jul 22;3:2050312115597087. doi: 10.1177/2050312115597087. eCollection 2015.
Patients categorized Rutherford category IV might have different characteristics compared with Rutherford category V and VI. Our study aims were to estimate the clinical differences between Rutherford category IV and Rutherford category V and VI, for those underwent endovascular therapy for isolated infrapopliteal disease, and also to find risk factors for endovascular therapy in Rutherford category IV.
Based on the Japanese multi-center registry data, 1091 patients with 1332 limbs (Rutherford category IV: 226 patients with 315 limbs, Rutherford category V and VI: 865 patients with 1017 limbs) were analyzed retrospectively.
Patients' backgrounds and lesions' characteristics had significant differences. Both freedom rate from major adverse limb event with perioperative death and amputation-free survival rate at 1 year were better in Rutherford category IV than Rutherford category V and VI (93.6% vs 78.3%, 87.7% vs 66.7%) and those maintained to 3 years (p < 0.0001). Significant predictors for major adverse limb event/perioperative death were small body mass index (<18.5 kg/m(3)) and initial endovascular therapy success, and those for amputation-free survival were small body mass index (<18.5 kg/m(3)), non-ambulatory status, high systematic inflammatory reaction (C-reactive protein > 3.0 mg/dL), chronic obstructive pulmonary disease, and coronary artery disease in Rutherford category IV.
From the present results, Rutherford category IV should be recognized to have quite different backgrounds and better outcome from Rutherford category V and VI.
与卢瑟福分级V级和VI级相比,卢瑟福分级IV级的患者可能具有不同的特征。我们的研究目的是评估接受孤立性腘下病变血管内治疗的卢瑟福分级IV级与卢瑟福分级V级和VI级之间的临床差异,并找出卢瑟福分级IV级血管内治疗的危险因素。
基于日本多中心注册数据,对1091例患者的1332条肢体进行回顾性分析(卢瑟福分级IV级:226例患者315条肢体,卢瑟福分级V级和VI级:865例患者1017条肢体)。
患者背景和病变特征存在显著差异。卢瑟福分级IV级患者围手术期死亡和截肢的主要不良肢体事件自由率以及1年无截肢生存率均优于卢瑟福分级V级和VI级(93.6%对78.3%,87.7%对66.7%),且这些指标维持至3年(p<0.0001)。卢瑟福分级IV级中,主要不良肢体事件/围手术期死亡的显著预测因素是低体重指数(<18.5kg/m³)和初始血管内治疗成功,无截肢生存的预测因素是低体重指数(<18.5kg/m³)、非行走状态、高全身炎症反应(C反应蛋白>3.0mg/dL)、慢性阻塞性肺疾病和冠状动脉疾病。
根据目前的结果,应认识到卢瑟福分级IV级与卢瑟福分级V级和VI级具有截然不同的背景和更好的预后。